Heparin is a promising agent for the treatment of endometriosis-associated fibrosis

Kaei Nasu, Akitoshi Tsuno, Marina Hirao, Hironao Kobayashi, Akitoshi Yuge, Hisashi Narahara
Fertility and sterility · 2009 · vol. 94(1) , pp. 46–51 · doi:10.1016/j.fertnstert.2009.02.057 · PMID:19338998 · W2133473958
article OA: bronze CC0 ⤵ 13 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated heparin as a potential treatment for endometriosis-associated fibrosis, finding it to be a promising agent.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Endometriosis Heparin Adult Animals Cattle Cells, Cultured Collagen Collagen Endometriosis Endometrium Endometrium Endometrium Female Fibrosis Heparin Heparin Humans Stromal Cells Stromal Cells

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (13)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:14:11.755070+00:00
License: CC0 · commercial use OK